Jun Ren

Receptor Conversion between Primary Tumors and Distant Metastases in 121 Cases of Metastatic Breast Cancer

B. Shao, Huiping Li, L. Di, 2013 .

Phase III clinical trials of the cell differentiation agent-2 (CDA-2): Therapeutic efficacy on breast cancer, non-small cell lung cancer and primary hepatoma1

C. Ling, Qiang Chen, Z. Meng, 2005 .

A multicenter phase II trial of domestic product of zoledronic acid in the treatment of malignant hypercalcemia

L. Di, Ying Yan, Jun Ren, 2007 .

Multicenter clinical study for evaluation of efficacy and safety of transdermal fentanyl matrix patch in treatment of moderate to severe cancer pain in 474 Chinese cancer patients

R. Wu, Jun Liang, G. Song, 2011, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

Global Development of Anticancer Therapies for Rare Cancers, Pediatric Cancers, and Molecular Subtypes of Common Cancers

H. Katayama, H. Lyerly, G. Reaman, 2018, Journal of global oncology.

Regional variation in identified cancer care needs of early-career oncologists in China, India, and Pakistan.

A. Abernethy, M. Stockler, Z. Aziz, 2015, The oncologist.

[Phase III clinical study of zoledronic acid in the treatment of pain induced by bone metastasis from solid tumor or multiple myeloma].

Yang Zhang, Qiang Chen, S. Jiao, 2008, Zhonghua zhong liu za zhi [Chinese journal of oncology].